Skip to main content
. 2012 Aug 11;380(9841):581–590. doi: 10.1016/S0140-6736(12)60367-5

Figure 5.

Figure 5

Predicted 5-year benefits of LDL cholesterol reductions with statin treatment at different levels of risk

(A) Major vascular events and (B) vascular deaths. Lifetable estimates using major vascular event risk or vascular death risk in the respective risk categories and overall treatment effects per 1·0 mmol/L reduction in LDL cholesterol with statin.